Mantra Bio
Drug Delivery
Mantra Bio valuation and funding history | Last updated: January 4, 2023 | 3 funding rounds
Current Valuation
N/A
As of January 4, 2023
Total Funding Raised
N/A
Across 3 rounds
Last Round
Later Stage VC (Series A2)
$9.0M
Last Funding
Jan 2023
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 4, 2023 | Later Stage VC (Series A2) | $9.0M | N/A | - |
| July 29, 2020 | Early Stage VC (Series A) | $25.0M | N/A | - |
| January 1, 2018 | Accelerator/Incubator | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Mantra Bio is currently valued at N/A as of January 4, 2023.
What is Mantra Bio Worth in 2026?
Mantra Bio is a leading private company in the Drug Delivery sector. Track Mantra Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Mantra Bio Valuation is Determined
Private company valuations like Mantra Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.